Copyright © 2012 M. Jawad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. G. G. Jackson, H. F. Dowling, I. G. Spiesman, and A. V. Boand, “Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity,” A.M.A. Archives of Internal Medicine, vol. 101, no. 2, pp. 267–278, 1958. View at Scopus
2. S. L. Johnston, “Cromolyns: treatment fo the common cold?” Clinical and Experimental Allergy, vol. 26, no. 9, pp. 989–994, 1996. View at Scopus
3. A. M. Fendrick, A. S. Monto, B. Nightengale, and M. Sarnes, “The economic burden of non-influenza-related viral respiratory tract infection in the United States,” Archives of Internal Medicine, vol. 163, no. 4, pp. 487–494, 2003. View at Publisher · View at Google Scholar · View at Scopus
4. A. S. Monto, “Individual and community impact of influenza,” PharmacoEconomics, vol. 16, supplement 1, pp. 1–6, 1999. View at Scopus
5. D. Wat, “The common cold: a review of the literature,” European Journal of Internal Medicine, vol. 15, no. 2, pp. 79–88, 2004. View at Publisher · View at Google Scholar · View at Scopus
6. H. A. Rotbart and F. G. Hayden, “Picornavirus infections: a primer for the practitioner,” Archives of Family Medicine, vol. 9, no. 9, pp. 913–920, 2000. View at Scopus
7. S. L. Johnston, “Problems and prospects of developing effective therapy for common cold viruses,” Trends in Microbiology, vol. 5, no. 2, pp. 58–63, 1997. View at Publisher · View at Google Scholar · View at Scopus
8. J. O. Hendley, “The host response, not the virus, causes the symptoms of the common cold,” Clinical Infectious Diseases, vol. 26, no. 4, pp. 847–848, 1998. View at Scopus
9. R. Jefferson, “Antivirals for the common cold,” in Common Cold: Verlag, R. W. O. Eccles, Ed., pp. 221–236, Birkhäuser, Basel, Switzerland, 2009.
10. B. Weinberger, D. Herndler-Brandstetter, A. Schwanninger, D. Weiskopf, and B. Grubeck-Loebenstein, “Biology of immune responses to vaccines in elderly persons,” Clinical Infectious Diseases, vol. 46, no. 7, pp. 1078–1084, 2008. View at Publisher · View at Google Scholar · View at Scopus
11. B. Grubeck-Loebenstein and G. Wick, “The aging of the immune system,” Advances in Immunology, vol. 80, pp. 243–284, 2002. View at Publisher · View at Google Scholar · View at Scopus
12. K. C. Bergmann, “Assessment of the clinical value of using an immunomodulator in recurrent respiratory infections,” Advances in Experimental Medicine and Biology, vol. 371, pp. 795–797, 1995. View at Scopus
13. B. Barrett, “Medicinal properties of Echinacea: a critical review,” Phytomedicine, vol. 10, no. 1, pp. 66–86, 2003. View at Publisher · View at Google Scholar · View at Scopus
14. S. Foster, Echinacea Nature's Immune Enhancer, Healing Arts Press, Rochester, Vt, USA, 1991.
15. C. Schoeneberger, “The influence of the immunostimulating effects of pressed juice from Echinacea purpurea on the course and severity of cold infections,” Forum Immunologie, vol. 8, pp. 18–22, 1992.
16. U. A. Schmidt and M. Schenk N, “Pflanzliches Immunstimulans senkt Häufigkeit grippaler Infekte,” Natur Und GanzheitsMedizin, vol. 3, pp. 277–281, 1990.
17. H. A. Cohen, I. Varsano, E. Kahan, E. M. Sarrell, and Y. Uziel, “Effectiveness of an herbal preparation containing Echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study,” Archives of Pediatrics and Adolescent Medicine, vol. 158, no. 3, pp. 217–221, 2004. View at Publisher · View at Google Scholar · View at Scopus
18. D. Melchart, E. Walther, K. Linde, R. Brandmaier, and C. Lersch, “Echinacea root extracts for the prevention of upper Respiratory tract Infections: a double-blind, placebo-controlled randomized trial,” Archives of Family Medicine, vol. 7, no. 6, pp. 541–545, 1998. View at Scopus
19. S. J. Sperber, L. P. Shah, R. D. Gilbert, T. W. Ritchey, and A. S. Monto, “Echinacea purpurea for prevention of experimental rhinovirus colds,” Clinical Infectious Diseases, vol. 38, no. 10, pp. 1367–1371, 2004. View at Publisher · View at Google Scholar · View at Scopus
20. R. B. Turner, D. K. Riker, and J. D. Gangemi, “Ineffectiveness of Echinacea for prevention of experimental rhinovirus colds,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 6, pp. 1708–1709, 2000. View at Publisher · View at Google Scholar · View at Scopus
21. R. B. Turner, R. Bauer, K. Woelkart, T. C. Hulsey, and J. D. Gangemi, “An evaluation of Echinacea angustifolia in experimental rhinovirus infections,” The New England Journal of Medicine, vol. 353, no. 4, pp. 341–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
22. R. Schoop, P. Klein, A. Suter, and S. L. Johnston, “Echinacea in the prevention of induced rhinovirus colds: a meta-analysis,” Clinical Therapeutics, vol. 28, no. 2, pp. 174–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
23. R. J. Tallarida, R. B. Murray, and C. Eiben, “A scale for assessing the severity of diseases and adverse drug reactions. Application to drug benefit and risk,” Clinical Pharmacology and Therapeutics, vol. 25, no. 4, pp. 381–390, 1979. View at Scopus
24. B. Barrett, B. Harahan, D. Brown, Z. Zhang, and R. Brown, “Sufficiently important difference for common cold: severity reduction,” Annals of Family Medicine, vol. 5, no. 3, pp. 216–223, 2007. View at Publisher · View at Google Scholar · View at Scopus
25. B. Barrett, S. Endrizzi, P. Andreoli, S. Barlow, and Z. Zhang, “Clinical significance of common cold treatment: professionals' opinions,” Wisconsin Medical Journal, vol. 106, no. 8, pp. 473–480, 2007. View at Scopus
26. E. Tiralongo, R. A. Lea, S. S. Wee, M. M. Hanna, and L. R. Griffiths, “Randomised, double blind, placebo-controlled trial of Echinacea supplementation in air travellers,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 417267, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
27. EMEA, “Community herbal monograph on Echinacea purpurea (L.) moench, herba recens,” in HMPC, EMEA, Ed., pp. 1–6, 2008.
28. D. J. Rowlands, “Rhinoviruses and cells: molecular aspects,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 4, pp. S31–S35, 1995. View at Scopus
29. T. J. Caruso and J. M. Gwaltney, “Treatment of the common cold with Echinacea: a structured review,” Clinical Infectious Diseases, vol. 40, no. 6, pp. 807–810, 2005. View at Publisher · View at Google Scholar · View at Scopus
30. M. B. H. Smith and W. Feldman, “Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991,” Journal of the American Medical Association, vol. 269, no. 17, pp. 2258–2263, 1993. View at Publisher · View at Google Scholar · View at Scopus
31. M. Sharma, S. A. Anderson, R. Schoop, and J. B. Hudson, “Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract,” Antiviral Research, vol. 83, no. 2, pp. 165–170, 2009. View at Publisher · View at Google Scholar · View at Scopus
32. S. Pleschka, M. Stein, R. Schoop, and J. B. Hudson, “Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian Influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV),” Virology Journal, vol. 6, article 197, 2009. View at Publisher · View at Google Scholar · View at Scopus